CARDIFF ONCOLOGY, INC. Ttl Offering Amt
CARDIFF ONCOLOGY, INC. (CRDF) had Ttl Offering Amt of $4.15 million as of 2026-07-21, per its S-8 filed 2026-07-21.
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-07-21
- 2026-07-21: Ttl Offering Amt $4.15M.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-07-21 | $4.15M S-8 · filed 2026-07-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |